C000220951 Performance — BlackRock LifePath ESG Index 2050 Fund, Institutional Class
Data updated: 2026-09-25
C000220951 returned +11.15% year to date and +21.45% over one year to Jul 2026. Annualised returns are +16.75% over 3 years and +9.57% over 5 years. The fund beat its Target-Date category average: $100 invested three years ago grew to $159, against $146 for the category, and to $121 over one year, against $116. Volatility over the past three years was 12.13% a year. In the 12 months to Jul 2026 the fund took in a net $6.1M, and assets reached $29.58M.
C000220951 Growth of $100
What $100 invested in BlackRock LifePath ESG Index 2050 Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Target-Date category average over the same months.
| Period | C000220951 | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $121 | $116 |
| 3 years (Aug 2023 – Jul 2026) | $159 | $146 |
| 5 years (Aug 2021 – Jul 2026) | $158 | $142 |
| Since data start (Aug 2020 – Jul 2026) | $206 | $174 |
C000220951 Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +11.15% |
| 1 year | +21.45% |
| 3 years (annualised) | +16.75% |
| 5 years (annualised) | +9.57% |
C000220951 Annual Returns
Calendar-year total returns of BlackRock LifePath ESG Index 2050 Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +11.15% |
| 2025 | +20.23% |
| 2024 | +15.10% |
| 2023 | +20.84% |
| 2022 | −18.59% |
| 2021 | +19.76% |
| 2020 (Aug–Dec) | +13.65% |
C000220951 Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +3.0% | +1.8% | −6.1% | +8.9% | +4.1% | 0.0% | −0.4% | — | — | — | — | — |
| 2025 | +2.9% | −0.6% | −3.4% | +0.5% | +5.3% | +4.5% | +0.7% | +2.9% | +3.2% | +1.8% | +0.2% | +0.8% |
| 2024 | −0.3% | +3.9% | +3.1% | −3.6% | +4.3% | +1.7% | +2.4% | +2.4% | +2.3% | −2.5% | +4.2% | −3.2% |
| 2023 | +7.7% | −3.0% | +2.4% | +1.3% | −1.4% | +5.6% | +3.5% | −2.8% | −4.4% | −3.0% | +9.0% | +5.4% |
| 2022 | −4.9% | −3.0% | +2.0% | −7.8% | +0.2% | −8.5% | +7.5% | −4.5% | −9.6% | +6.5% | +8.1% | −4.3% |
| 2021 | −0.2% | +2.9% | +3.2% | +4.1% | +1.9% | +1.0% | +1.1% | +2.3% | −4.0% | +5.2% | −2.9% | +4.1% |
| 2020 | — | — | — | — | — | — | — | +1.6% | −3.1% | −2.2% | +12.8% | +4.7% |
C000220951 Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 12.13%
- 3-year Sharpe ratio: 1.01 (vs 4.5% risk-free rate)
- Best month: +8.99% (Nov 2023)
- Worst month: −6.13% (Mar 2026)
C000220951 Fund Flows
Monthly money in and out of BlackRock LifePath ESG Index 2050 Fund, from SEC Form N-PORT.
- 12-month net flow: $6.1M
- 12-month gross sales (incl. reinvestments): $9.7M
- Sales ÷ redemptions: 2.64×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $376K | $341K | $35K |
| Jun 2026 | $1.9M | $317K | $1.5M |
| May 2026 | $976K | $359K | $617K |
| Apr 2026 | $766K | $804K | −$38K |
| Mar 2026 | $724K | $55K | $669K |
| Feb 2026 | $520K | $132K | $387K |
| Jan 2026 | $426K | $437K | −$11K |
| Dec 2025 | $666K | $302K | $365K |
| Nov 2025 | $285K | $259K | $26K |
| Oct 2025 | $978K | $379K | $599K |
| Sep 2025 | $394K | $85K | $308K |
| Aug 2025 | $1.8M | $214K | $1.6M |
C000220951 Assets Under Management
Net assets of BlackRock LifePath ESG Index 2050 Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $29.58M |
| 2026-04-30 | $26.40M |
| 2026-01-31 | $24.36M |
| 2025-10-31 | $23.41M |
| 2025-07-31 | $19.23M |
| 2025-04-30 | $9.38M |
| 2025-01-31 | $9.26M |
| 2024-10-31 | $7.99M |
| 2024-07-31 | $7.88M |
| 2024-04-30 | $6.92M |
| 2024-01-31 | $6.56M |
| 2023-10-31 | $4.68M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.